[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355384-105":59,"doc-detail-355384-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","close-to-patient-models-for-gastric-cancer-original-research","Close-to-Patient Models for Gastric Cancer - Original Research","","Gastric cancer is highly lethal and often diagnosed late, with substantial intratumor heterogeneity and a dense stromal microenvironment that limits the translation of simple preclinical findings into clinical success. This study establishes fibroblast-rich, close-to-patient models and evaluates their robustness against primary gastric tumor tissue from the corresponding patients. Five models were generated, including PDX, organoid, and a multicellular fibroblast-rich mini-tumor system, with comparative histology, immunohistochemistry, mutational profiling, and tumor/stroma composition to assess fidelity and clinical relevance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/close-to-patient-models-for-gastric-cancer-original-research/355384/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/close-to-patient-models-for-gastric-cancer-original-research/355384.png","ImageObject",300,407,{"name":92,"@type":93},"Jacob","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are conventional systemic therapies less effective for gastric cancer?","Question",{"text":112,"@type":113},"Late diagnosis, high intratumor heterogeneity, and a dense stromal compartment reduce sensitivity to systemic treatments, and preclinical data from simple cell-based models may not translate to the complex tumor structure and drug resistance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What types of close-to-patient models were established in this study?",{"text":117,"@type":113},"Five models were developed: subcutaneous and orthotopic patient-derived xenografts, an in vitro patient-derived organoid, an in vivo subcutaneously engrafted organoid, and a novel multicellular fibroblast-rich model cocultured with gastric cancer fibroblasts.",{"name":119,"@type":110,"acceptedAnswer":120},"How did the models perform compared with primary patient tissues?",{"text":121,"@type":113},"The models preserved key histological structures and maintained primary tumor mutations, while orthotopic approaches showed high growth with stromal accumulation and fibroblast-rich multicellular cultures formed complex structures with high similarity to parental gastric tumors.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355384,1790358301,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084931830,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","OncoTargets and Therapy  \n Open Access Full Text Article  \nORIGINAL RESEARCH  \nClose-to-Patient Models for Gastric Cancer: From Patient-Derived Xenograft Towards a Novel Gastric Cancer Mini-Tumor Model  \nSarah K Hakuno 1 , *, Joëlle Zonneveld 1 , *, Stefanus GT Janson 1 , Anthea Van der Wielen 1 , Eleonore B Kuhlemaijer 1 , Maud Steenbakkers 1 , Leonie Plug 1 , Eveline De Jonge-Muller 1 , Eduard P De Winter2 , Margreet R De Vries2 , Tom Van Wezel 3 , Stijn Crobach 3 , Lukas JAC Hawinkels 1 , *, Andrea Vallés-Martí 1 , *, Marije Slingerland 4 , *  \n1Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands; 2Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands; 3Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands; 4Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands  \n*These authors contributed equally to this work  \nCorrespondence: Lukas JAC Hawinkels, Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, 2300, the Netherlands, Tel +31 71 526 6736, Email [l.j.a.c.hawinkels@lumc.nl](l.j.a.c.hawinkels@lumc.nl)  \n\n| Purpose: Gastric cancer (GC) is the fifth most lethal form of cancer. Because of its late diagnosis, high intratumor heterogeneity, and the presence of a dense stromal compartment, GC is less susceptible to systemic treatments compared to other tumor types. Many systemic therapies, developed to support curative and palliative treatment for GC and other cancers, did not reach the clinic, which might be due to the fact that preclinical data, obtained from simple cell-based models, does not translate to the complex GC tumor structure and the occurrence of drug resistance. Therefore, this study is aimed to establish fibroblast-rich, close-to-patient models for GC and evaluate their robustness by comparison with the primary GC tissue from the respective patients.\u003Cbr>Material and Methods: Five different GC models were established: I) a subcutaneous and II) orthotopic patient-derived xenograft (PDX) model, III) an in vitro patient-derived organoid (PDO) model, which was IV) subcutaneously engrafted in vivo, and V) cocultured with GC fibroblasts to form a novel multicellular fibroblast-rich GC model. Histology, immunohistochemistry, mutational status and tumor/stroma composition were compared between the parental tissues and the various models.\u003Cbr>Results: Both PDX models reflected the histological structure of the parental tissue, consisting of distinct parenchymal and stromal compartments. Primary tumor mutations were maintained in the PDX, as well as markers of clinical interest, like HER2 . Orthotopic GC-PDX models showed high growth rates, accompanied by significant stromal accumulation. GC-PDOs showed histological similarities with parental tissues, maintaining the various histological phenotypes. Engrafted subcutaneously in mice, these organoids generated stroma-rich tumors. To mimic these features in vitro, we established a multicellular model composed of GC-associated fibroblasts and GC organoids, aggregating into complex multicellular structures with high similarity to parental GC tumor tissues. Conclusion: We generated five close-to-patient GC models, which can potentially facilitate preclinical evaluations of novel therapies.\u003Cbr>Keywords: stomach, carcinoma, stroma, patient-derived organoid, patient-derived xenograft |\n| --- |\n| Introduction\u003Cbr>Gastric cancer (GC) is the fifth most prevalent and lethal cancer, with close to 1 million new cases and approximately 650,000 deaths worldwide in 2022, respectively.1 The lethality ofGC is due to many factors, including late diagnosis, the highly metastatic capacity of the tumors, and tumor heterogeneity, based on histology, genomics, and topography. These characteristics contribute greatly to the relatively poor 5-year survival of around 35% .2 The cornerstone of curative therapy for GC is a mult","cbCaifwdIzyXepMj","https://ap.wps.com/l/cbCaifwdIzyXepMj","pdf",10698434,15,"English","# Purpose\n## Material and Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"Why are conventional systemic therapies less effective for gastric cancer?\",\"answer\":\"Late diagnosis, high intratumor heterogeneity, and a dense stromal compartment reduce sensitivity to systemic treatments, and preclinical data from simple cell-based models may not translate to the complex tumor structure and drug resistance.\"},{\"question\":\"What types of close-to-patient models were established in this study?\",\"answer\":\"Five models were developed: subcutaneous and orthotopic patient-derived xenografts, an in vitro patient-derived organoid, an in vivo subcutaneously engrafted organoid, and a novel multicellular fibroblast-rich model cocultured with gastric cancer fibroblasts.\"},{\"question\":\"How did the models perform compared with primary patient tissues?\",\"answer\":\"The models preserved key histological structures and maintained primary tumor mutations, while orthotopic approaches showed high growth with stromal accumulation and fibroblast-rich multicellular cultures formed complex structures with high similarity to parental gastric tumors.\"}]","Close-to-Patient Models for Gastric Cancer - Original Research | PDF",1790118309,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4712f79faa263fcfd9217476ac0877d.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7205462ed42335206b38d0c7d8c72b3.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ac971c3f79bb66ef0ad4c0f3ffd41a0b.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e945885ebc72eb3f8ceeec464f5bf73f.webp",980,1268]